| Q37361431 | 2-Carbaborane-3-phenyl-1H-indoles--synthesis via McMurry reaction and cyclooxygenase (COX) inhibition activity. |
| Q27001623 | Automated solid-phase peptide synthesis to obtain therapeutic peptides |
| Q107552783 | Carbaboranes – more than just phenyl mimetics |
| Q98153815 | Carborane-containing Matrix Metalloprotease (MMP) Ligands as Candidates for Boron Neutron Capture Therapy (BNCT) |
| Q38882129 | Controlling toxicity of Peptide-drug conjugates by different chemical linker structures |
| Q90061826 | Enlargement of a Modular System-Synthesis and Characterization of an s-Triazine-Based Carboxylic Acid Ester Bearing a Galactopyranosyl Moiety and an Enormous Boron Load |
| Q107552670 | Half- and mixed-sandwich metallacarboranes for potential applications in medicine |
| Q92524582 | NPY1R-targeted peptide-mediated delivery of a dual PPARα/γ agonist to adipocytes enhances adipogenesis and prevents diabetes progression |
| Q98178368 | Peptide-Drug Conjugates and Their Targets in Advanced Cancer Therapies |
| Q33919544 | Position and length of fatty acids strongly affect receptor selectivity pattern of human pancreatic polypeptide analogues |
| Q85843454 | Receptor-mediated uptake of boron-rich neuropeptide y analogues for boron neutron capture therapy |
| Q92940596 | Synthesis and Characterization of Phosphorus- and Carborane-Containing Polyoxanorbornene Block Copolymers |
| Q61449422 | Synthesis of a tubugi-1-toxin conjugate by a modulizable disulfide linker system with a neuropeptide Y analogue showing selectivity for hY1R-overexpressing tumor cells |
| Q90729270 | Unusually persistent Gαi-signaling of the neuropeptide Y2 receptor depletes cellular Gi/o pools and leads to a Gi-refractory state |